STOCK TITAN

[Form 4] WEX Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Ann Elena Drew, Chief Risk and Compliance at WEX Inc., reported the sale of 1,931 shares of common stock on 08/06/2025 at a price of $171.69, leaving 7,295 shares held directly. The Form 4 shows no derivative securities transactions. The filing is signed by an attorney-in-fact, documenting routine insider disclosure of a stock sale.

Ann Elena Drew, Chief Risk and Compliance di WEX Inc., ha segnalato la vendita di 1,931 azioni ordinarie il 08/06/2025 al prezzo di $171.69, restando titolare di 7,295 azioni detenute direttamente. Il Modulo 4 non indica operazioni su strumenti derivati. La dichiarazione è firmata da un procuratore, documentando la consueta comunicazione interna relativa a una vendita di azioni.

Ann Elena Drew, directora de Riesgo y Cumplimiento de WEX Inc., informó la venta de 1,931 acciones ordinarias el 08/06/2025 a un precio de $171.69, quedando con 7,295 acciones en propiedad directa. El Formulario 4 no registra operaciones con valores derivados. La presentación está firmada por un apoderado y documenta la divulgación interna rutinaria de una venta de acciones.

Ann Elena Drew, WEX Inc.의 리스크 및 준법감시 책임자는 08/06/2025에 보통주 1,931주를 주당 $171.69에 매도했다고 신고했으며, 직접 보유한 주식은 7,295주로 남아 있습니다. Form 4에는 파생상품 거래가 기재되어 있지 않습니다. 제출 서류는 권한대리인이 서명했으며, 이는 통상적인 내부자 주식 매각 공시입니다.

Ann Elena Drew, responsable du risque et de la conformité chez WEX Inc., a déclaré la vente de 1,931 actions ordinaires le 08/06/2025 au prix de $171.69, conservant 7,295 actions détenues directement. Le formulaire 4 n'indique aucune opération sur des instruments dérivés. Le dépôt est signé par un mandataire et documente la divulgation interne de routine d'une vente d'actions.

Ann Elena Drew, Leiterin für Risiko und Compliance bei WEX Inc., meldete den Verkauf von 1,931 Stammaktien am 08/06/2025 zu je $171.69, womit sie 7,295 direkt gehaltene Aktien behält. Das Formular 4 weist keine Transaktionen mit Derivaten aus. Die Einreichung ist von einem Bevollmächtigten unterzeichnet und dokumentiert die routinemäßige Insider-Offenlegung eines Aktienverkaufs.

Positive
  • Transaction disclosed transparently: sale quantity, price, and post-transaction ownership are reported
  • No derivative transactions reported in Table II, simplifying the disclosure
Negative
  • Insider sale of 1,931 shares was executed, reducing direct holdings
  • Reduction in holdings from the sale (post-transaction ownership: 7,295 shares)

Insights

TL;DR: Insider sale disclosed; modest share sale leaves significant direct ownership — neutral near-term impact.

The Form 4 reports a sale of 1,931 WEX shares at $171.69 on 08/06/2025, leaving 7,295 shares owned directly by the reporting officer. As a single routine disposition with continued substantial ownership, this transaction is informational and does not, by itself, indicate a material change to the company’s outlook.

TL;DR: Filing appears properly completed and signed by attorney-in-fact; disclosure standards met.

The Form 4 identifies the reporting person as Ann Elena Drew, Chief Risk and Compliance, and documents the sale and post-transaction ownership. Table II contains no derivative entries and the signature block shows execution by an attorney-in-fact, indicating procedural compliance with Section 16 reporting requirements.

Ann Elena Drew, Chief Risk and Compliance di WEX Inc., ha segnalato la vendita di 1,931 azioni ordinarie il 08/06/2025 al prezzo di $171.69, restando titolare di 7,295 azioni detenute direttamente. Il Modulo 4 non indica operazioni su strumenti derivati. La dichiarazione è firmata da un procuratore, documentando la consueta comunicazione interna relativa a una vendita di azioni.

Ann Elena Drew, directora de Riesgo y Cumplimiento de WEX Inc., informó la venta de 1,931 acciones ordinarias el 08/06/2025 a un precio de $171.69, quedando con 7,295 acciones en propiedad directa. El Formulario 4 no registra operaciones con valores derivados. La presentación está firmada por un apoderado y documenta la divulgación interna rutinaria de una venta de acciones.

Ann Elena Drew, WEX Inc.의 리스크 및 준법감시 책임자는 08/06/2025에 보통주 1,931주를 주당 $171.69에 매도했다고 신고했으며, 직접 보유한 주식은 7,295주로 남아 있습니다. Form 4에는 파생상품 거래가 기재되어 있지 않습니다. 제출 서류는 권한대리인이 서명했으며, 이는 통상적인 내부자 주식 매각 공시입니다.

Ann Elena Drew, responsable du risque et de la conformité chez WEX Inc., a déclaré la vente de 1,931 actions ordinaires le 08/06/2025 au prix de $171.69, conservant 7,295 actions détenues directement. Le formulaire 4 n'indique aucune opération sur des instruments dérivés. Le dépôt est signé par un mandataire et documente la divulgation interne de routine d'une vente d'actions.

Ann Elena Drew, Leiterin für Risiko und Compliance bei WEX Inc., meldete den Verkauf von 1,931 Stammaktien am 08/06/2025 zu je $171.69, womit sie 7,295 direkt gehaltene Aktien behält. Das Formular 4 weist keine Transaktionen mit Derivaten aus. Die Einreichung ist von einem Bevollmächtigten unterzeichnet und dokumentiert die routinemäßige Insider-Offenlegung eines Aktienverkaufs.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Drew Ann Elena

(Last) (First) (Middle)
C/O WEX INC.
1 HANCOCK STREET

(Street)
PORTLAND ME 04101

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
WEX Inc. [ WEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Risk and Compliance
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/06/2025 S 1,931 D $171.69 7,295 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Matthew Finkelstein, as attorney-in-fact for Ann Elena Drew 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for WEX (WEX) disclose?

The Form 4 discloses a sale of 1,931 shares on 08/06/2025 at $171.69, leaving 7,295 shares held directly.

Who is the reporting person on the WEX Form 4?

The reporting person is Ann Elena Drew, identified as Chief Risk and Compliance at WEX Inc.

How many WEX shares does the reporting person own after the transaction?

The Form 4 reports 7,295 shares beneficially owned directly following the reported transaction.

Were any derivative securities reported in the filing?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned.

Who signed the Form 4 on behalf of the reporting person?

The form is signed by Matthew Finkelstein, as attorney-in-fact for Ann Elena Drew.
Wex Inc

NYSE:WEX

WEX Rankings

WEX Latest News

WEX Latest SEC Filings

WEX Stock Data

5.89B
33.83M
1.02%
117.6%
5.22%
Software - Infrastructure
Services-business Services, Nec
Link
United States
PORTLAND